FDA announced the decision to approve the GLP-1 receptor agonist, semaglutide (Wegovy), to reduce the risk of CV death, heart attack, and stroke in adults with CVD and obesity or overweight.

A March 7 report in CDC’s Morbidity and Mortality Weekly Report (MMWR) highlights the continued need to educate parents and other caregivers about the importance of keeping all medications and supplements—including melatonin gummies—out of children’s reach.

FDA’s Vaccines and Related Biological Products Advisory Committee recommended that regulators drop the quadrivalent influenza vaccines used for roughly the past decade or so in favor of a trivalent replacement.

New research published in JAMA Internal Medicine shows that opioid analgesics elevate the likelihood of falls in all adult patients, but the greatest risk is among individuals aged 85 years and older.

FDA released a safety alert February 21 warning patients about the dangers of smartwatches or smart rings that claim to gauge blood glucose levels without requiring the user to pierce their skin.